Target intelligence / Profile preview

MARK2 pseudogene 4 (MARK2P4)

Target
MARK2P4
Molecular classification
Other (Pseudogene)
01

Overview

MARK2 pseudogene 4 (MARK2P4) is classified as a **pseudogene** related to the functional gene Microtubule Affinity Regulating Kinase 2 (MARK2), which encodes a serine/threonine protein kinase involved in cell polarity, microtubule regulation, and phosphorylation of microtubule-associated proteins[1]. However, pseudogenes such as MARK2P4 do **not code for functional proteins**, and there is no evidence in scientific databases or literature to suggest that MARK2P4 is a **drug target**, codes any functional product, or is implicated in disease mechanisms or drug response. The correct MARK2 gene is protein-coding and is associated with various cellular functions and diseases, but there is no indication that the pseudogene MARK2P4 has any such biological or therapeutic relevance[1][5]. Additionally, no major repositories document interacting drugs, biomarker status, or safety concerns related to MARK2P4. **Note:** - There appears to be potential confusion between MARK2 (the functional kinase) and the pseudogene MARK2P4; the literature and gene databases do not support MARK2P4 as a valid molecular drug target or a gene with known biological function. - MARK2P4 should not be used interchangeably with MARK2, and there is no evidence that it functions as a receptor, enzyme, transporter, or therapeutic target. If you require information about the functional kinase **MARK2** (Microtubule Affinity Regulating Kinase 2)—which *is* a serine/threonine-protein kinase implicated in cell polarity and microtubule dynamics[1]—please specify, as the gene and pseudogene are functionally distinct.

Other names
MAP/microtubule affinity-regulating kinase 2 pseudogene 4microtubule affinity regulating kinase 2 pseudogene 4MARK2P4

Beyond the preview

Go deeper on MARK2 pseudogene 4 (MARK2P4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MARK2 pseudogene 4 (MARK2P4).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call